Rapid Communication
Copyright ©2007 Baishideng Publishing Group Co.
World J Gastroenterol. Jun 21, 2007; 13(23): 3232-3236
Published online Jun 21, 2007. doi: 10.3748/wjg.v13.i23.3232
Table 1 Grading of the inflammatory activity in chronic hepatitis according to Ishak et al (the maximum possible scoring is 18)
Score
Portal inflammation
None0
Mild, some or all portal areas1
Moderate, some or all portal areas2
Moderate/severe, all portal areas3
Severe, all portal areas4
Periportal or periseptal interface hepatitis (“piecemeal necrosis”)
Absent0
Mild (focal, few portal areas)1
Mild/moderate (focal, most portal areas)2
Moderate (continuous around < 50% of tracts or septa)3
Severe (continuous around > 50% of tracts or septa)4
Focal parenchymal necrosis
Absent0
1 focus or less per visual field of 100 × magnification1
2-4 foci per 100 × magnification2
5-10 foci per 100 × magnification3
More than 10 foci per 100 × magnification4
Confluent necrosis
Absent0
Focal confluent necrosis1
Zone 3 necrosis in some areas2
Zone 3 necrosis in most areas3
Zone 3 necrosis and occasional portal-central bridging4
Zone 3 necrosis and multiple portal-central bridging5
Panacinar or multiacinar necrosis6
Table 2 Stages according to the METAVIR criteria (Bedossa et al)
Stage 0No fibrosis
Stage 1Mild fibrosis (portal/periportal fibrosis, no septa)
Stage 2Moderate fibrosis (few septa)
Stage 3Severe fibrosis (many septa, no cirrosis)
Stage 4Cirrhosis
Table 3 Clinical characteristics of patients with AIH before tacrolimus treatment
PatientGenderAgePrednisoloneAdditionalHLA typeALTIgGINRBilirubinAlbuminCreatinineFollow-up
No.(yr)doseimmonusupression(U/L)(g/L)(μmol/L)(g/L)(μmol/L)(mo)
1F6420MMFN.A.271151.1937.88837
2F3220AZADR-3156291.63028.07120
3F4920MMFDR-4,15109181.11334.78534
4F2040AZAN.A.10212.30.91343.05518
5F1720AZADR-17, DQ247530.21.014639.15913
6M1680AZADR-7,17154161.5837.16517
7F5525AZADR-4,13100171.15837.14912
8F4920AZADR-4,7202101.21542.26612
9F3220MMFN.A.126161.1633.36836